Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice https://www.biorxiv.org/content/10.1101/2023.04.25.538294v1?med=mas
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice https://www.biorxiv.org/content/10.1101/2023.04.25.538294v1?med=mas